Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cilium induction triggers differentiation of glioma stem cells.
Goranci-Buzhala G, Mariappan A, Ricci-Vitiani L, Josipovic N, Pacioni S, Gottardo M, Ptok J, Schaal H, Callaini G, Rajalingam K, Dynlacht B, Hadian K, Papantonis A, Pallini R, Gopalakrishnan J. Goranci-Buzhala G, et al. Cell Rep. 2021 Sep 7;36(10):109656. doi: 10.1016/j.celrep.2021.109656. Cell Rep. 2021. PMID: 34496239 Free article.
Chemotherapy resistance of glioblastoma stem cells.
Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R. Eramo A, et al. Cell Death Differ. 2006 Jul;13(7):1238-41. doi: 10.1038/sj.cdd.4401872. Epub 2006 Feb 3. Cell Death Differ. 2006. PMID: 16456578 No abstract available.
Colon cancer stem cells.
Ricci-Vitiani L, Pagliuca A, Palio E, Zeuner A, De Maria R. Ricci-Vitiani L, et al. Gut. 2008 Apr;57(4):538-48. doi: 10.1136/gut.2007.127837. Gut. 2008. PMID: 18334662 Review. No abstract available.
Mesenchymal differentiation of glioblastoma stem cells.
Ricci-Vitiani L, Pallini R, Larocca LM, Lombardi DG, Signore M, Pierconti F, Petrucci G, Montano N, Maira G, De Maria R. Ricci-Vitiani L, et al. Cell Death Differ. 2008 Sep;15(9):1491-8. doi: 10.1038/cdd.2008.72. Epub 2008 May 23. Cell Death Differ. 2008. PMID: 18497759
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells.
Ciceroni C, Arcella A, Mosillo P, Battaglia G, Mastrantoni E, Oliva MA, Carpinelli G, Santoro F, Sale P, Ricci-Vitiani L, De Maria R, Pallini R, Giangaspero F, Nicoletti F, Melchiorri D. Ciceroni C, et al. Neuropharmacology. 2008 Sep;55(4):568-76. doi: 10.1016/j.neuropharm.2008.06.064. Epub 2008 Jul 8. Neuropharmacology. 2008. PMID: 18621067
123 results